Health Board Logo. Post SARS Outbreak Surveillance. Report of possible or probable cases (Form version 1) February 11 th 2004

Similar documents
PPHSN Reporting Form Severe acute respiratory syndrome (SARS) outbreak

Severe Acute Respiratory Syndrome (SARS) Updated Guidelines for the Global Surveillance of SARS. August 22 nd 2005

Chapter. Severe Acute Respiratory Syndrome (SARS) Outbreak in a University Hospital in Hong Kong. Epidemiology-University Hospital Experience

Human Infection with Novel Influenza A Virus Case Report Form

Severe Acute Respiratory Infection (SARI) Guidelines. Chief Public Health Office Department of Health & Wellness

Dr. Cristina Gutierrez, Laboratory Director, CARPHA SARI/ARI SURVEILLANCE IN CARPHA MEMBER STATES

2,040 reported laboratory-confirmed cases 712 deaths in 27 countries. A single imported case of MERS in South Korea, identified on 20 May 2015,

WHO guidelines for the global surveillance of severe acute respiratory syndrome (SARS)

INFLUENZA (Outbreaks; hospitalized or fatal pediatric cases)

Human infection with pandemic (H1N1) 2009 virus: updated interim WHO guidance on global surveillance

Avian Influenza Clinical Picture, Risk profile & Treatment

NCCID RAPID REVIEW. 1. What are the case definitions and guidelines for surveillance and reporting purposes?

LEARNING FROM OUTBREAKS: SARS

Appendix B: Provincial Case Definitions for Reportable Diseases

BCCDC Measles, Mumps and Rubella Enhanced Surveillance Case Report Form

Microbiology Laboratory Directors, Infection Preventionists, Primary Care Providers, Emergency Department Directors, Infectious Disease Physicians

Surveillance Protocol for SARS - Draft

Transmission of Infectious Disease on Aircraft

Title: National Surveillance for Severe Acute Respiratory Syndrome (SARS-CoV)

Severe Acute Respiratory Syndrome ( SARS )

BC MHOs, PHNLs, ICPs, ERDOCs, IDSPEC, MEDMICRO, AMBULANCE, BCCDC Internal Groups, National Surveillance Network Partners

Epidemiological News Bulletin

Swine Influenza Update #3. Triage, Assessment, and Care of Patients Presenting with Respiratory Symptoms

Unwell returned traveller

Novel Coronavirus 2012

Influenza-Associated Pediatric Mortality rev Jan 2018

FACT SHEET FOR ADDITIONAL INFORMATION CONTACT

SARS and the Clinical Laboratory

Interim WHO guidance for the surveillance of human infection with swine influenza A(H1N1) virus

Antimicrobial Stewardship in Community Acquired Pneumonia

MERS CoV Outbreak Riyadh, July-Aug 2015

WHO Regional Office for Europe summary of Middle East respiratory syndrome coronavirus (MERS-CoV) Situation update and overview of available guidance

A rash case Infection control management of measles

Original Article ABSTRACT INTRODUCTION MATERIAL AND METHODS. Ibrahim Saifi Al Harbi 1, Sanjay Kumar Gupta 2, * Objectives

Newfoundland and Labrador Influenza Surveillance Reporting Requirements

Measles Elimination Dr. Suzanne Cotter 4 th National Immunisation Conference 2007

The Triple Axel: Influenza, TB and MERS-CoV. Carolyn Pim, MD December 10, 2015

Respiratory Viruses Policy

CDHB Infection Prevention and Control Community Liaison

Highlights. NEW YORK CITY DEPARTMENT OF HEALTH AND MENTAL HYGIENE Influenza Surveillance Report Week ending January 28, 2017 (Week 4)

Of Camels, Bats and Coronaviruses: the (beginning of the) story of MERS-CoV

Influence of Social Media on an Acute Respiratory Outbreak at a High Profile Party Venue Los Angeles, February 2011

British Columbia Institute of Technology. BCIT Safety Manual SARS VIRUS EXPOSURE CONTROL PLAN

Guidance for Influenza in Long-Term Care Facilities

SOP Objective To provide Healthcare Workers (HCWs) with details of the precautions necessary to minimise the risk of RSV cross-infection.

Influenza Activity in Indiana

Patient Details. Other: Chemotherapy Long term steroids Organ transplant Splenectomy HIV CD4 count if known:

PEDIATRIC INFLUENZA CLINICAL PRACTICE GUIDELINES

INDEX CASE INFORMATION

Influenza at the human-animal interface

MARYLAND DEPARTMENT OF HEALTH AND MENTAL HYGIENE John M. Colmers, Secretary

Reporting of Severe and Fatal Pediatric Influenza New Jersey Department of Health Influenza Season

Influenza Outbreak Control Measure Trigger Tool for Care Homes

Infection control in Aged Residential Care Facilities. Dr Sally Roberts Clinical Advisor for IP&C Service, ADHB

This SOP applies to all staff employed by NHS Greater Glasgow & Clyde and locum staff on fixed term contracts and volunteer staff.

Community Acquired Pneumonia. Abdullah Alharbi, MD, FCCP

Dr Mary O Meara Specialist in Public Health Medicine November /9/2013 1

Winter vomiting disease (norovirus)

National Response to SARS: Singapore. TAN Chorh Chuan Director of Medical Services Ministry of Health, Singapore

Evolution of the Hospital Capacity for SARS in Taipei

Pertussis. West Virginia Electronic Disease Surveillance System

SITUATIONAL REPORT. Cluster of Meningococcal Disease in Foya District, Lofa County Liberia. 27th January 2018

Avian Influenza A(H7N9) 13 February 2014 Surveillance Update

Policy Objective. This policy applies to all staff employed by NHS Greater Glasgow & Clyde and locum staff on fixed term contracts.

H5N1 / Avian Influenza Essentials. Quick Reference for Providers and Public Health Officials

Surveillance, Reporting and Control of Influenza and Pertussis. Steve Fleming, EdM Hillary Johnson, MHS Epidemiologists Immunization Program, MDPH

Polio (Paralytic and Non-paralytic

Middle East Respiratory Syndrome Coronavirus

PERSONAL CARE HOME/LONG TERM CARE FACILITY INFLUENZA OUTBREAK MANAGEMENT PROTOCOL

Information for Primary Care: Managing patients who require assessment for Ebola virus disease Updated 17 Oct 2014

JOB A IDS for collection, storage and transport of specimens for laboratory confirmation of Middle East respiratory syndrome coronavirus (MERS-CoV)

Spotlight on measles 2010: A cluster of measles in a hospital setting in Slovenia, March 2010

point-of-care test (POCT) Definition: an analytical or diagnostic test undertaken in a setting distinct from a normal hospital or non-hospital

This SOP applies to all staff employed by NHS Greater Glasgow & Clyde and locum staff on fixed term contracts and volunteer staff.

Appendix B: Provincial Case Definitions for Reportable Diseases

Weekly Influenza Activity: Statistics Summary

Current and Emerging Legionella Diagnostics

Weekly Influenza & Respiratory Activity: Statistics Summary

Haemophilus influenzae, Invasive Disease rev Jan 2018

Early February Surveillance of severe atypical pneumonia in Hospital Authority in Hong Kong. Initiate contacts in Guangdong

CONTROL OF VIRAL GASTROENTERITIS OUTBREAKS IN CALIFORNIA LONG-TERM CARE FACILITIES

Public Health Perspectives: Coordination the Response to Imported Infectious Disease Threats in New York City

UPDATE IN HOSPITAL MEDICINE

Infection Prevention & Control Guidelines for the Management of Influenza and Respiratory Viral Illness

Alberta Health Public Health Notifiable Disease Management Guidelines January 2013

Information collected from influenza surveillance allows public health authorities to:

2014/2015 Ottawa County Influenza Surveillance Summary

DEPARTMENT OF HEALTH AND MENTAL HYGIENE. nyc.gov/health

IP Lab Webinar 8/23/2012

Emerging respiratory infections: MERS and beyond. Victoria Johnston Hospital for Tropical Diseases

MEASLES HEALTH ALERT/ADVISORY. Date: February 5, Dear Colleague:

Congregate Care Facilities

Foreword. Health protection service bulletin December HIV and sexually transmitted infections (STIs) in Northern Ireland.

ORIGINAL ARTICLE /j x

Epidemiological Report: Influenza A/H1N1 Malta 15 July 2009

Spots and Pox: Contact Tracing and Follow Up for Measles and Chickenpox

Surveillance and Epidemiological Investigation

Spots and Pox: Contact Tracing and Follow Up for Measles and Chickenpox

Summary of current outbreak in Guinea, Liberia and Sierra Leone

Emerging Respiratory Infections NZ Amanda McNaughton Respiratory Physician CCDHB Wellington

Transcription:

Post SARS Outbreak Surveillance Report of possible or probable cases (Form version 1) February 11 th 2004 This form is to be used for persons who fit the surveillance case definition of possible or probable SARS when there is no evidence of SARS transmission (person-to-person) globally. The cases to be reported are those conforming to the case definitions provided by the WHO/EU in the absence of SARS transmission (person-to-person) globally, which are reproduced at the bottom of this form. Date of report: ame of reporter: Position: Institution/organisation Telephone/Fax/E-mail: PATIET DETAILS ame of patient: Sex Date of birth Home address M F Telephone Country of Residence (If different from home address) Reporting Form Post SARS Outbreak Version 1.0 February 04 Page 1 of 13

Occupation & place of work Date when last at work GP ame Address Telephone/Fax/Email HOSPITAL ADMISSIO Admitted to hospital? If yes, give name of hospital. Currently admitted? If yes, date of admission Transferred to other hospital If yes, name of hospital Date of transfer Date of Discharge CLIICAL DETAILS Current Health Status If the patient died Date of Onset of Illness Recovering Moderately ill Severely ill Ventilated Died Date of Death Autopsy Documented or reported fever History of fever (not documented) Reporting Form Post SARS Outbreak Version 1.0 February 04 Page 2 of 13

Symptoms High fever (>38 0 c) Cough Myalgia Dyspnoea/difficulty breathing Diarrhoea Other If other please specify: Clinical diagnosis Pneumonia ARDS Other If other please give details Severity of Illness ot very ill Moderately ill Severely ill RISK FACTORS Is the Patient a Healthcare Worker? If es, where is their place of employment? Were other possible SARS Cases /cases of unexplained pneumonia associated with the healthcare facility Have close contacts of case been diagnosed with unexplained pneumonia If ES in either/both of the two above, please give details Reporting Form Post SARS Outbreak Version 1.0 February 04 Page 3 of 13

History of recent travel? Close contact* with a possible or probable SARS Case or close contact with ill person who returned from zone of reemergence in the last 10 days. If yes, please give details in terms of dates, place and nature of exposure to case. Definition of close contact is outlined on Page 8 Does the person work in a laboratory which undertakes work/research on SARS If yes, give details IVESTIGATIOS General Investigations Chest X-Ray Date of CXR / / Result ormal Abnormal FBC Date of FBC / / Thrombocytopenia Leucopenia Serology (to be sent to ational Virus Reference Laboratory for analysis) Acute Serum (if symptomatic at time of assessment) Result Date serum obtained / / Convalescent Serum (taken 14 days after acute serum or 14 days after onset of illness) Result Date convalescent serum taken / / Bacteriology Serology for atypical pneumonia (Mycoplasma, Chlamydia etc.) Result Blood Culture Result Sputum (if available) Result Reporting Form Post SARS Outbreak Version 1.0 February 04 Page 4 of 13

Urinary Antigen for Legionella Result Virology Serum Result asopharyngeal Aspirate Result Viral Throat Swab Result Oral Washings Result PLACE OF POTETIAL EXPOSURE Has the patient travelled outside of Ireland since August 1 2003? If yes complete following section Country /area visited Date of Return to Ireland Country of Departure Airport of arrival in Ireland Was person symptomatic on the flight 1. Dates of visit: from to 2. Dates of visit: from to 3. Dates of visit: from to 4. Dates of visit: from to Reporting Form Post SARS Outbreak Version 1.0 February 04 Page 5 of 13

Airflight Details Other comments Carrier Airline Flight umbers Outbound Inbound Date and time of Arrival at Destination Date: / / Time:. am/pm Date and time of Departure from Destination Date: / / Time:. am/pm Accomadation Details Includes apartments, campsites, cruise ships etc. Country Town Hotel Room umber if available From / / to / / Country Town Hotel Room umber if available From / / to / / Additional Comments Reporting Form Post SARS Outbreak Version 1.0 February 04 Page 6 of 13

PLEASE LEAVE BLAK (For Public Health Department Purposes Only) Final Diagnosis (as per Case Definitions) Confirmed SARS Probable SARS Possible SARS Laboratory Acquired SARS Other Please specify Please return this form by fax to Dr., Director of Public Health, Fax: Tel: Reporting Form Post SARS Outbreak Version 1.0 February 04 Page 7 of 13

SARS: Details of contacts (from 10 days prior to onset) Patient ame: Patient Address: Tel: Form completed by: Position: Date: ame, address, tel number D.O.B Relationship to patient ature of contact (e.g. healthcare facility, household, work, social). Total hours of contact with case in previous 10 days GP name, address, tel number Contact tracing form completed Status of Contact i.e. Possible, Probable Confirmed Case Reporting Form Post SARS OB Version 1.0 February 2004 Page 8 of 13

Reporting Form Post SARS OB Version 1.0 February 2004 Page 9 of 13

The following case definitions apply to the surveillance of SARS in the absence of known transmission (person-to person) worldwide. 1 Clinical Case Definition of SARS The following case definition of SARS is consistent with the WHO clinical case definition and has been developed for public health purposes. The respiratory illness usually will be severe enough to warrant hospitalisation and include a history of: Fever of 38 C (documented or reported) AD One or more symptoms of lower respiratory tract illness (cough, difficulty breathing, shortness of breath) AD Radiographic evidence of lung infiltrates consistent with pneumonia or respiratory distress syndrome (RDS) or autopsy findings consistent with the pathology of pneumonia or RDS without an identifiable cause. AD o alternative diagnosis to fully explain the illness. It is important that clinicians obtain a detailed travel history from patients with symptoms and signs consistent with clinical SARS as well as ascertain whether other family members and/or close contacts (particularly within the hospital setting) have had a similar illness within the 10 days prior to the patient s onset of illness. 2 Possible Case a) Individual Case A person fulfilling the clinical case definition of SARS (see 1) Reporting Form Post SARS OB Version 1.0 February 2004 Page 10 of 13

AD within ten days of onset of illness, a history of travel to an area classified by WHO as a potential zone of re-emergence of SARS (this includes an area identified as the source of the ovember 2002 outbreak and/or an area with increased likelihood of animal to human transmission of SARS-CoV infection). b) Health Care Worker (HCW) Cluster Two or more HCWs in the same health care facility fulfilling the clinical case definition of SARS (see above) and with onset of illness within the same 10- day period. The definition of the health care unit in which the cluster occurs will depend on the local situation. Unit size may range from an entire health care facility if small, to a single department or ward of a large tertiary hospital. This constitutes SARS Alert c) Other Hospital Cluster Hospital acquired illness in three or more persons (health care workers and/or other hospital staff and/or patients and/or visitors) in (or linked to) the same health care unit fulfilling the clinical case definition of SARS (see above) and with onset of illness within the same 10-day period. This constitutes SARS Alert In order to detect a cluster of SARS in the healthcare setting, clinicians are asked to notify cases of unexplained pneumonia in healthcare workers to the Medical Officer of Health (Director of Public Health). All healthcare workers should be asked to inform the Occupational Health Physician/Department if they develop signs of severe pneumonia that requires hospital admission. 3 Probable Case An individual with symptoms and signs consistent with clinical SARS (Possible Case) AD with preliminary laboratory evidence of SARS-CoV based on the following: Either Single positive antibody test for SARS-CoV Or Positive PCR for SARS-CoV on a single clinical specimen and assay Reporting Form Post SARS OB Version 1.0 February 2004 Page 11 of 13

.4 Laboratory acquired probable case An ill person who has developed the symptoms reported below in the 10 days following working with or having been in contact with a laboratory activity involved with SARS-CoV manipulation: Fever (>38 C) One or more respiratory symptoms including cough, difficulty breathing, shortness of breath And Radiographic evidence of lung infiltrates consistent with pneumonia or respiratory distress syndrome. This person should be considered as a SARS probable case and managed accordingly until the contrary is proven. 5 Confirmed Case An individual with symptoms and signs consistent with clinical SARS (Possible Case) AD with laboratory evidence of SARS-CoV infection based on one or more of the following: a) PCR positive for SARS-CoV using a validated method from: OR At least two different clinical specimens (e.g. nasopharyngeal and stool) The same clinical specimen collected on two or more occasions during the course of the illness (e.g. sequential nasopharyngeal aspirates) OR Two different assays or repeat PCR using a new RA extract from the original clinical sample on each occasion of testing. b) Seroconversion by ELISA or IFA egative antibody test on acute serum followed by positive antibody test on convalescent phase serum tested in parallel OR Fourfold or greater rise in antibody titre between acute and convalescent phase sera tested in parallel. Reporting Form Post SARS OB Version 1.0 February 2004 Page 12 of 13

c) Virus isolation Isolation in cell culture of SARS-CoV from any specimen AD PCR confirmation using a validated method. Testing should only be undertaken in a national or regional reference laboratory as per WHO recommendations (Use of laboratory methods for SARS diagnosis). 6 Denotified Case A case is denotified when 1. An alternative laboratory diagnosis is made which can fully explain the illness OR 2. The patient has a negative convalescent serology result (ote: negative PCR result does not result in the declassification of a possible case). Reporting Form Post SARS OB Version 1.0 February 2004 Page 13 of 13